Evonik Industries (FRA:EVK) PT Set at €29.60 by Goldman Sachs Group
Goldman Sachs Group set a €29.60 ($34.42) price objective on Evonik Industries (FRA:EVK) in a research report released on Monday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.
A number of other research analysts have also weighed in on EVK. Berenberg Bank set a €30.00 ($34.88) price objective on Evonik Industries and gave the company a buy rating in a report on Wednesday, November 6th. HSBC set a €25.00 ($29.07) price objective on Evonik Industries and gave the company a neutral rating in a report on Wednesday, September 18th. Morgan Stanley set a €34.00 ($39.53) price objective on Evonik Industries and gave the company a buy rating in a report on Monday, July 15th. DZ Bank reissued a buy rating on shares of Evonik Industries in a report on Wednesday, November 6th. Finally, Credit Suisse Group set a €25.00 ($29.07) price objective on Evonik Industries and gave the company a neutral rating in a report on Tuesday, November 5th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and nine have issued a buy rating to the stock. Evonik Industries currently has an average rating of Hold and an average target price of €28.19 ($32.78).
Shares of EVK stock traded down €0.24 ($0.28) during mid-day trading on Monday, reaching €25.83 ($30.03). The stock had a trading volume of 1,129,394 shares. The business’s fifty day moving average is €23.66 and its 200-day moving average is €24.29. Evonik Industries has a 1-year low of €26.78 ($31.14) and a 1-year high of €32.97 ($38.34).
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
See Also: What is the Dividend Aristocrat Index?
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.